Compounds > medroxyprogesterone acetate
Page last updated: 2024-08-17

medroxyprogesterone acetate and Abnormalities, Congenital

medroxyprogesterone acetate has been researched along with Abnormalities, Congenital in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19903 (75.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (25.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chen, Q; Hong, Q; Kuang, Y; Lu, X; Mao, X; Wang, Y; Zhang, J1

Other Studies

4 other study(ies) available for medroxyprogesterone acetate and Abnormalities, Congenital

ArticleYear
Neonatal outcomes and congenital malformations in children born after human menopausal gonadotropin and medroxyprogesterone acetate treatment cycles.
    Archives of gynecology and obstetrics, 2017, Volume: 296, Issue:6

    Topics: Birth Weight; Child; Congenital Abnormalities; Embryo Transfer; Female; Fertilization in Vitro; Gestational Age; Humans; Infant, Newborn; Live Birth; Medroxyprogesterone Acetate; Menopause; Menotropins; Ovulation Induction; Parturition; Perinatal Mortality; Pregnancy; Pregnancy Outcome; Retrospective Studies; Twins; Vitrification

2017
DMPA for contraception discussed by international forum of experts.
    Network - International Fertility Research Program, 1979

    Topics: Congenital Abnormalities; Contraception; Contraceptive Agents; Contraceptive Agents, Female; Disease; Evaluation Studies as Topic; Family Planning Services; Infertility; Injections; Medroxyprogesterone Acetate; Neoplasms

1979
First Asian Workshop on Injectable Contraceptives.
    IPPF medical bulletin, 1978, Volume: 12, Issue:3

    Topics: Asia; Congenital Abnormalities; Contraception; Contraceptive Agents; Contraceptive Agents, Female; Developing Countries; Evaluation Studies as Topic; Family Planning Services; Injections; Medroxyprogesterone Acetate

1978
Injectable contraceptives: how safe are they?
    Initiatives in population, 1979, Volume: 5, Issue:4

    Topics: Congenital Abnormalities; Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Contraception; Contraceptive Agents; Contraceptive Agents, Female; Developing Countries; Disease; Evaluation Studies as Topic; Family Planning Services; Government Agencies; Injections; Lactation; Medroxyprogesterone Acetate; Philippines; Public Policy; Reproductive Control Agents

1979